447 related articles for article (PubMed ID: 30635355)
1. Tumor-infiltrating human CD4
Ahmadzadeh M; Pasetto A; Jia L; Deniger DC; Stevanović S; Robbins PF; Rosenberg SA
Sci Immunol; 2019 Jan; 4(31):. PubMed ID: 30635355
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
[No Abstract] [Full Text] [Related]
3. The T-cell receptor repertoire of regulatory T cells.
Pacholczyk R; Kern J
Immunology; 2008 Dec; 125(4):450-8. PubMed ID: 19128356
[TBL] [Abstract][Full Text] [Related]
4. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
Gros A; Parkhurst MR; Tran E; Pasetto A; Robbins PF; Ilyas S; Prickett TD; Gartner JJ; Crystal JS; Roberts IM; Trebska-McGowan K; Wunderlich JR; Yang JC; Rosenberg SA
Nat Med; 2016 Apr; 22(4):433-8. PubMed ID: 26901407
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma.
Bräunlein E; Lupoli G; Füchsl F; Abualrous ET; de Andrade Krätzig N; Gosmann D; Wietbrock L; Lange S; Engleitner T; Lan H; Audehm S; Effenberger M; Boxberg M; Steiger K; Chang Y; Yu K; Atay C; Bassermann F; Weichert W; Busch DH; Rad R; Freund C; Antes I; Krackhardt AM
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34518289
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3
Mannie MD; DeOca KB; Bastian AG; Moorman CD
Cell Immunol; 2020 Sep; 355():104173. PubMed ID: 32712270
[TBL] [Abstract][Full Text] [Related]
7. Global analysis of T-cell groups reveals immunological features and common antigen targets of digestive tract tumors.
Li X; Zhang Y; Guo S; Wu Z; Wang H; Huang Y; Wang Y; Qiu M; Lang J; Xiao Y; Zhu Y; Jin G; Hu L; Kong X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):129. PubMed ID: 38488909
[TBL] [Abstract][Full Text] [Related]
8. Inventories of naive and tolerant mouse CD4 T cell repertoires reveal a hierarchy of deleted and diverted T cell receptors.
Hassler T; Urmann E; Teschner S; Federle C; Dileepan T; Schober K; Jenkins MK; Busch DH; Hinterberger M; Klein L
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18537-18543. PubMed ID: 31451631
[TBL] [Abstract][Full Text] [Related]
9. High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells.
Föhse L; Suffner J; Suhre K; Wahl B; Lindner C; Lee CW; Schmitz S; Haas JD; Lamprecht S; Koenecke C; Bleich A; Hämmerling GJ; Malissen B; Suerbaum S; Förster R; Prinz I
Eur J Immunol; 2011 Nov; 41(11):3101-13. PubMed ID: 21932448
[TBL] [Abstract][Full Text] [Related]
10. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
11. Clonality of CD4
Arakawa A; Vollmer S; Tietze J; Galinski A; Heppt MV; Bürdek M; Berking C; Prinz JC
Front Immunol; 2019; 10():1336. PubMed ID: 31275310
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.
Hindley JP; Ferreira C; Jones E; Lauder SN; Ladell K; Wynn KK; Betts GJ; Singh Y; Price DA; Godkin AJ; Dyson J; Gallimore A
Cancer Res; 2011 Feb; 71(3):736-46. PubMed ID: 21156649
[TBL] [Abstract][Full Text] [Related]
13. The mechanisms shaping the repertoire of CD4
Kraj P; Ignatowicz L
Immunology; 2018 Mar; 153(3):290-296. PubMed ID: 29106696
[TBL] [Abstract][Full Text] [Related]
14. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.
Kuczma M; Kopij M; Pawlikowska I; Wang CY; Rempala GA; Kraj P
PLoS One; 2010 Oct; 5(10):e13623. PubMed ID: 21049016
[TBL] [Abstract][Full Text] [Related]
16. Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells.
Cai B; Ma P; Ding P; Sun DW; Bu Q; Zhang J
APMIS; 2020 Mar; 128(3):260-269. PubMed ID: 31811667
[TBL] [Abstract][Full Text] [Related]
17. Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.
Gros A; Tran E; Parkhurst MR; Ilyas S; Pasetto A; Groh EM; Robbins PF; Yossef R; Garcia-Garijo A; Fajardo CA; Prickett TD; Jia L; Gartner JJ; Ray S; Ngo L; Wunderllich JR; Yang JC; Rosenberg SA
J Clin Invest; 2019 Nov; 129(11):4992-5004. PubMed ID: 31609250
[TBL] [Abstract][Full Text] [Related]
18. Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells.
Wong J; Obst R; Correia-Neves M; Losyev G; Mathis D; Benoist C
J Immunol; 2007 Jun; 178(11):7032-41. PubMed ID: 17513752
[TBL] [Abstract][Full Text] [Related]
19. The T-cell receptor repertoire of tumor-infiltrating regulatory T lymphocytes is skewed toward public sequences.
Sainz-Perez A; Lim A; Lemercier B; Leclerc C
Cancer Res; 2012 Jul; 72(14):3557-69. PubMed ID: 22573714
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
Jacobs JF; Nierkens S; Figdor CG; de Vries IJ; Adema GJ
Lancet Oncol; 2012 Jan; 13(1):e32-42. PubMed ID: 22225723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
